Nordic Capital, Five Arrows to Sell The Binding Site in $2.61 Billion Deal
31 10월 2022 - 9:17PM
Dow Jones News
By Dominic Chopping
STOCKHOLM--Swedish private-equity firm Nordic Capital said
Monday it has agreed to sell specialty diagnostics company The
Binding Site to Thermo Fisher Scientific Inc. in a deal valued at
2.25 billion pounds ($2.61 billion).
Nordic Capital has been the majority owner of The Binding Site
since 2011 when it completed the acquisition together with Five
Arrows, the alternative assets arm of Rothschild & Co.
Nordic Capital and Five Arrows have now entered a definitive
agreement to sell The Binding Site, with the deal expected to be
completed in the first half of 2023, subject to closing
conditions.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
October 31, 2022 08:02 ET (12:02 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Rothschild (EU:ROTH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Rothschild (EU:ROTH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
